These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18220562)

  • 1. The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.
    Liu X; Jia L
    Curr Drug Metab; 2007 Dec; 8(8):815-21. PubMed ID: 18220562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conduct of drug metabolism studies considered good practice (II): in vitro experiments.
    Jia L; Liu X
    Curr Drug Metab; 2007 Dec; 8(8):822-9. PubMed ID: 18220563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdosing assessment to evaluate pharmacokinetics and drug metabolism in rats using liquid chromatography-tandem mass spectrometry.
    Ni J; Ouyang H; Aiello M; Seto C; Borbridge L; Sakuma T; Ellis R; Welty D; Acheampong A
    Pharm Res; 2008 Jul; 25(7):1572-82. PubMed ID: 18299965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology.
    Kamel A; Prakash C
    Curr Drug Metab; 2006 Dec; 7(8):837-52. PubMed ID: 17168686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nano-electrospray for metabolite identification and quantitative absorption, distribution, metabolism and excretion studies.
    Hop CE
    Curr Drug Metab; 2006 Jun; 7(5):557-63. PubMed ID: 16787163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical tools and approaches for metabolite identification in early drug discovery.
    Chen Y; Monshouwer M; Fitch WL
    Pharm Res; 2007 Feb; 24(2):248-57. PubMed ID: 17048114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.
    Grangeon A; Gravel S; Gaudette F; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():144-158. PubMed ID: 27978469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of mass spectrometry for metabolite identification.
    Ma S; Chowdhury SK; Alton KB
    Curr Drug Metab; 2006 Jun; 7(5):503-23. PubMed ID: 16787159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New analytical strategies in studying drug metabolism.
    Staack RF; Hopfgartner G
    Anal Bioanal Chem; 2007 Aug; 388(7):1365-80. PubMed ID: 17583803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the "Metabolites in Safety Testing" Regulatory Guidance.
    Schadt S; Bister B; Chowdhury SK; Funk C; Hop CECA; Humphreys WG; Igarashi F; James AD; Kagan M; Khojasteh SC; Nedderman ANR; Prakash C; Runge F; Scheible H; Spracklin DK; Swart P; Tse S; Yuan J; Obach RS
    Drug Metab Dispos; 2018 Jun; 46(6):865-878. PubMed ID: 29487142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
    Baumann A; Karst U
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.